SHARMEH P/E Ratio
Current P/E Ratio
25.48
High Valuation
High - Growth expectations or overvalued
SHARMEH (SHARMEH) P/E ratio is 25.48 (High), EPS (TTM) ₹3.78, current price ₹94.00 on BSE — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see SHARMEH share price chart.
Current Valuation Metrics
P/E Ratio
25.48
Current Price
₹94.00
EPS (TTM)
₹3.78
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
95.06
Sector Median
44.49
Sector Rank
#11 of 57
Sector Percentile
19.3%
SHARMEH P/E Ratio — Valuation Signal & Historical Context
SHARMEH P/E 25.48 — signal: Overvalued.
- Stock appears overvalued with PE of 25.48, suggesting caution for new investments
- Trading at discount to sector average PE of 95.06
SHARMEH vs Healthcare Services Peers — P/E Ratio Comparison
SHARMEH P/E 25.48 vs Healthcare Services average 95.06, median 44.49 — range 7.19–1587.86.
Sector Average
95.06
Sector Median
44.49
Lowest P/E
7.19
Highest P/E
1587.86
Companies
57
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 7.19 | ₹135 | Low |
| Abate AS Industries | ABATEAS | 10.42 | ₹132 | Low |
| Deccan Health Care | DECCAN | 12.09 | ₹31 | Low |
| Nidan Labs & Healthcare | NIDAN | 12.27 | ₹19 | Low |
| One Global Service Provi… | ONEGLOBAL | 14.06 | ₹1,053 | Low |
| Shanmuga Hospital | SHANMUGA | 15.88 | ₹67 | Moderate |
| Invicta Diagnostic | INVICTA | 17.27 | ₹82 | Moderate |
| Indraprastha Medical Cor… | INDRAMEDCO | 17.69 | ₹3,355 | Moderate |
| Krsnaa Diagnostics | KRSNAA | 18.39 | ₹1,757 | Moderate |
| Chandan Healthcare | CHANDAN | 18.55 | ₹500 | Moderate |